NVAX
Price
$4.28
Change
-$0.02 (-0.47%)
Updated
Apr 12, 6:59 PM EST
22 days until earnings call
THRD
Price
$11.52
Change
-$0.46 (-3.84%)
Updated
Apr 12, 6:59 PM EST
24 days until earnings call
Ad is loading...

Compare predictions NVAX vs THRD

Header iconNVAX vs THRD Comparison
Open Charts NVAX vs THRDBanner chart's image
Novavax
Price$4.28
Change-$0.02 (-0.47%)
Volume$2.43M
CapitalizationN/A
Third Harmonic Bio
Price$11.52
Change-$0.46 (-3.84%)
Volume$390.7K
CapitalizationN/A
View a ticker or compare two or three
NVAX vs THRD Comparison Chart

Loading...

NVAXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
THRDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
NVAX vs. THRD commentary
Apr 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVAX is a Hold and THRD is a Sell.

COMPARISON
Comparison
Apr 15, 2024
Stock price -- (NVAX: $4.65 vs. THRD: $8.74)
Brand notoriety: NVAX: Notable vs. THRD: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVAX: 52% vs. THRD: 61%
Market capitalization -- NVAX: $650.78M vs. THRD: $384.34M
NVAX [@Biotechnology] is valued at $650.78M. THRD’s [@Biotechnology] market capitalization is $384.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $568.84B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVAX’s FA Score shows that 0 FA rating(s) are green whileTHRD’s FA Score has 1 green FA rating(s).

  • NVAX’s FA Score: 0 green, 5 red.
  • THRD’s FA Score: 1 green, 4 red.
According to our system of comparison, THRD is a better buy in the long-term than NVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVAX’s TA Score shows that 5 TA indicator(s) are bullish while THRD’s TA Score has 4 bullish TA indicator(s).

  • NVAX’s TA Score: 5 bullish, 4 bearish.
  • THRD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, NVAX is a better buy in the short-term than THRD.

Price Growth

NVAX (@Biotechnology) experienced а -3.33% price change this week, while THRD (@Biotechnology) price change was -0.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.71%. For the same industry, the average monthly price growth was +6.49%, and the average quarterly price growth was +103.81%.

Reported Earning Dates

NVAX is expected to report earnings on May 07, 2024.

THRD is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (+4.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for NVAX with price predictions.
OPEN
A.I.dvisor published
a Summary for THRD with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
NVAX($651M) has a higher market cap than THRD($384M). NVAX YTD gains are higher at: -3.125 vs. THRD (-20.328). THRD has higher annual earnings (EBITDA): -43.92M vs. NVAX (-487.39M). NVAX has more cash in the bank: 569M vs. THRD (269M). THRD has less debt than NVAX: THRD (3.95M) vs NVAX (229M). NVAX has higher revenues than THRD: NVAX (556M) vs THRD (0).
NVAXTHRDNVAX / THRD
Capitalization651M384M170%
EBITDA-487.39M-43.92M1,110%
Gain YTD-3.125-20.32815%
P/E RatioN/A12.45-
Revenue556M0-
Total Cash569M269M212%
Total Debt229M3.95M5,793%
FUNDAMENTALS RATINGS
NVAX: Fundamental Ratings
NVAX
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
79
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVAXTHRD
RSI
ODDS (%)
Bearish Trend 15 days ago
89%
Bullish Trend 25 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 15 days ago
87%
Bullish Trend 15 days ago
90%
Momentum
ODDS (%)
Bearish Trend 15 days ago
86%
Bearish Trend 15 days ago
81%
MACD
ODDS (%)
Bearish Trend 15 days ago
85%
Bearish Trend 15 days ago
55%
TrendWeek
ODDS (%)
Bearish Trend 15 days ago
90%
Bullish Trend 15 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 15 days ago
88%
Bearish Trend 15 days ago
64%
Advances
ODDS (%)
Bullish Trend about 1 month ago
82%
Bullish Trend 20 days ago
90%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 15 days ago
77%
BollingerBands
ODDS (%)
N/A
Bullish Trend 15 days ago
90%
Aroon
ODDS (%)
Bullish Trend 15 days ago
83%
Bearish Trend 15 days ago
45%
View a ticker or compare two or three
Ad is loading...
NVAXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
THRDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
INSCX20.32N/A
N/A
Catalyst Insider Buying C
ASMZX13.99N/A
N/A
Alger Weatherbie Specialized Growth Z
TDFIX8.07-0.04
-0.49%
Transamerica Sustainable Equity Inc I
HFMRX31.57-0.16
-0.50%
Hartford MidCap R3
FITIX22.15-0.17
-0.76%
Fidelity Advisor Mid Cap II M

NVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVAX has been loosely correlated with CRSP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NVAX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVAX
1D Price
Change %
NVAX100%
-2.72%
CRSP - NVAX
47%
Loosely correlated
+0.03%
THRD - NVAX
42%
Loosely correlated
-7.42%
XNCR - NVAX
38%
Loosely correlated
-0.77%
SYRE - NVAX
38%
Loosely correlated
-2.29%
MRNA - NVAX
35%
Loosely correlated
-0.90%
More

THRD and

Correlation & Price change

A.I.dvisor indicates that over the last year, THRD has been loosely correlated with SYRE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if THRD jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THRD
1D Price
Change %
THRD100%
-7.42%
SYRE - THRD
49%
Loosely correlated
-2.29%
NVAX - THRD
42%
Loosely correlated
-2.72%
CPRX - THRD
28%
Poorly correlated
-1.32%
VNDA - THRD
28%
Poorly correlated
+0.24%
ABCL - THRD
26%
Poorly correlated
-1.77%
More